Results 181 to 190 of about 116,257 (347)

Phage therapy for treatment of virulent Klebsiella pneumoniae infection in a mouse model

open access: hybrid, 2019
Taruna Anand   +8 more
openalex   +1 more source

Phage Therapy at the Crossroads Between Clinical Promise and Regulatory Challenge. [PDF]

open access: yesPharmaceuticals (Basel)
Gallina A   +5 more
europepmc   +1 more source

Phage/nanoparticle cocktails for a biocompatible and environmentally friendly antibacterial therapy [PDF]

open access: gold
Mateusz Wdowiak   +8 more
openalex   +1 more source

More Than Microbiome and Medicine

open access: yes
Microbiota Medicine Research, EarlyView.
Faming Zhang   +2 more
wiley   +1 more source

An intracellular recombinant single‐chain variable antibody fragment as a new class of phosphodiesterase type 5 inhibitors

open access: yesBritish Journal of Pharmacology, EarlyView.
Background and Purpose Cyclic guanosine monophosphate (cGMP) is a ubiquitous second messenger involved in human (patho‐)physiology. Phosphodiesterase 5 (PDE5) is a major cGMP hydrolyzing enzyme in many cell types including vascular smooth muscle cells (VSMCs). Several highly selective PDE5 inhibitors are in clinical use. However, there are currently no
Kürsat Kirkgöz   +8 more
wiley   +1 more source

Phage therapy in revision arthroplasty: State of the art and application protocols. [PDF]

open access: yesArthroplasty
Wolfgart JM   +9 more
europepmc   +1 more source

Phosphatase PPP1CC Regulates the First Lineage Segregation by GAS5 in Mouse Preimplantation Embryos

open access: yesCell Proliferation, EarlyView.
Subcortical GAS5 directs PPP1CC phosphatase spatiotemporal positioning during mouse morula‐blastocyst transition, controlling YAP dephosphorylation to drive first embryonic lineage specification. ABSTRACT The transcriptional effector of the Hippo signalling pathway, YAP, regulates the first lineage specification in mouse preimplantation embryos ...
Jianwu Wang   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy